More than 2.5 million bottles of a widely prescribed corticosteroid eye drop are now the subject of a nationwide recall, and patients deserve to understand exactly how this unfolded, what risks are involved, and what legal options may be available if they were harmed. <\/p>\n\n\n\n
Below, we break down the recall in a clear timeline, followed by what affected patients should do next. <\/p>\n\n\n\n
Prednisolone acetate ophthalmic suspension, USP, 1% is a corticosteroid eye drop commonly prescribed to treat eye inflammation. Physicians typically prescribe it for: <\/p>\n\n\n\n
The medication is manufactured by Lupin Limited, a pharmaceutical company based in India with a broad portfolio of generic drugs, including several ophthalmic products. <\/p>\n\n\n\n
June 4, 2026 \u2014 Recall Initially Posted<\/strong> The FDA first posted the recall notice for Lupin’s prednisolone acetate eye drops. The action was prompted by the discovery of a foreign substance in the product. <\/p>\n\n\n\n June 30, 2026 \u2014 FDA Classifies the Recall as Class II<\/strong> Nearly a month later, the FDA formally classified the recall as a Class II event. Under FDA guidelines, a Class II classification means using or being exposed to the affected product could cause temporary or medically reversible health problems, or that the chance of serious harm is considered low, but not zero. <\/p>\n\n\n\n Ongoing \u2014 Scope of the Recall Confirmed<\/strong> According to the FDA’s enforcement report, the recall ultimately covers 2,530,182 bottles across three sizes: <\/p>\n\n\n\n Because the recall spans dozens of lot numbers across three bottle sizes, patients and providers are urged to check the FDA’s full enforcement report for the complete list of affected lots rather than relying on partial summaries. <\/p>\n\n\n\n It’s not the first time the FDA has had to take action against dangerous eye drops, in 2023<\/a> they issued an alert for twenty-six products<\/a> from the following brands: CVS Health, Leader (Cardinal Health), Rugby (Cardinal Health), Rite Aid, Target Up&Up and Velocity Pharma. <\/p>\n\n\n\n If you or a loved one has been using prednisolone acetate ophthalmic suspension, take the following steps: <\/p>\n\n\n\n When a pharmaceutical company distributes contaminated medication, particularly one applied directly to the eye, patients who suffer complications may have grounds for a product liability claim. Potential injuries<\/strong> linked to contaminated ophthalmic products can include eye infections, corneal damage, vision impairment, or worsening of the underlying condition the medication was meant to treat. <\/p>\n\n\n\n If you experienced any eye-related injury or complication after using a recalled Lupin prednisolone acetate product, an attorney can help you understand whether the manufacturer’s negligence contributed to your harm, and what compensaci\u00f3n<\/a> may be available for medical expenses, lost wages, and pain and suffering. <\/p>\n\n\n\n\n
\n
\n
What Patients Should Do Now<\/strong> <\/h2>\n\n\n\n
\n
\n
\n
\n
\n
Could You Have a Legal Claim?<\/strong> <\/h2>\n\n\n\n
Talk to Napoli Shkolnik About Your Recall Rights<\/strong> <\/h2>\n\n\n\n